Drug treatment of Parkinson's disease: is "polypharmacy" best?

Early contributions to the neurochemistry of sodium and potassium transport.

Neurochemistry international·2010

Losses in semiconductor waveguide S bends fabricated by impurity-induced layer disordering.

Optics letters·2009

Low-loss semiconductor waveguide bends.

Optics letters·2009

Neural transplantation in Huntington disease: long-term grafts in two patients.

Neurology·2007

Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes.

Neurology·2003

Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease.

Pharmacogenetics·2001

PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophy.

Journal of neurology, neurosurgery, and psychiatry·2026

Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.

Journal of neurology, neurosurgery, and psychiatry·2026

Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrence.

Journal of neurology, neurosurgery, and psychiatry·2026

Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Journal of neurology, neurosurgery, and psychiatry·2026

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

Journal of neurology, neurosurgery, and psychiatry·2026

MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.

Journal of neurology, neurosurgery, and psychiatry·2026

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches.

Clinical pharmacology and therapeutics·2026

Atorvastatin Safety Reappraised: From Pharmacogenomic Mechanisms to Personalized Risk Management.

Cardiovascular therapeutics·2026

Consumer Views on the Role of the Natural Health Products (NHPs) Industry in Pharmacovigilance for NHPs: A Qualitative Study in New Zealand.

Drug safety·2026

Proteins from platelet-enriched preparations as candidate biomarkers for major depressive disorder: An exploratory proteomic study.

Journal of affective disorders·2026

Effects of Repeated Ketamine Infusions on Suicidal Ideation in Treatment-Resistant Depression and Associated Changes in Selected Plasma Biomarkers.

Pharmacopsychiatry·2026

Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.

AIDS (London, England)·2026

Related Experiment Videos

Drug treatment of Parkinson's disease: is "polypharmacy" best?

Related Concept Videos

Early contributions to the neurochemistry of sodium and potassium transport.

Losses in semiconductor waveguide S bends fabricated by impurity-induced layer disordering.

Low-loss semiconductor waveguide bends.

Neural transplantation in Huntington disease: long-term grafts in two patients.

Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes.

Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease.

PABPN1 pathogenic expansion in the UK Biobank: reframing genetic prevalence of oculopharyngeal muscular dystrophy.

Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.

Stroke recurrence after primary intracerebral haemorrhage: a population-based study of clinical and MRI factors associated with recurrence.

Comparative effectiveness of inebilizumab versus conventional immunotherapies in AQP4-IgG-positive NMOSD: a prospective cohort study with time-varying treatment effects.

Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

MRI activity in pre-symptomatic multiple sclerosis: the role of paramagnetic rim lesions beyond the 2024 McDonald diagnostic criteria.

Evaluating Vaginal Microbiome Effects on Antiretroviral Exposure in the Female Genital Tract Using Pharmacometric and Machine Learning Approaches.

Atorvastatin Safety Reappraised: From Pharmacogenomic Mechanisms to Personalized Risk Management.

Consumer Views on the Role of the Natural Health Products (NHPs) Industry in Pharmacovigilance for NHPs: A Qualitative Study in New Zealand.

Proteins from platelet-enriched preparations as candidate biomarkers for major depressive disorder: An exploratory proteomic study.

Effects of Repeated Ketamine Infusions on Suicidal Ideation in Treatment-Resistant Depression and Associated Changes in Selected Plasma Biomarkers.

Real-life durability and virological outcomes of doravirine in people with multidrug-resistant HIV.

Related Experiment Videos

Drug treatment of Parkinson's disease: is "polypharmacy" best?

Related Concept Videos

Related Articles